Skip Navigation
  Print Page

A 15-Year Followup Report on Participants in the Collaborative Study of Children Treated for Phenylketonuria (PKUCS 1967-1984)

Skip sharing on social media links
Share this:

By Richard Koch, M.D., Barbara Burton, M.D., James Coldwell, M.D., George E. Hoganson, Jr., M.D., Michael Geraghty, M.D., Raymond M. Peterson, M.D., William J. Rhead, M.D., Ph.D., Bobbye M. Rouse, M.D., Ronald C. Scott, M.D., Carol Shear, M.D., Jon A. Wolff, M.D., Alan Stern, Ph.D., and Colleen G. Azen, M.S.

The study design, methods, and results of the 1967-1984 study were published and strongly supported a recommendation that a phenylalanine (Phe)-restricted diet should be maintained throughout adolescence (Holtzman, Kronmal, van Doorninck, et al., 1916.66%; Azen, Koch, Friedman, et al., 1991). This recommendation was based on an evaluation of the Wechsler Intelligence Scale for Children-Revised (WISC-R) and the Wide Range Achievement Test (WRAT) standard scores at the age of 12 years for 95 children who had been diagnosed by newborn screening and had begun dietary treatment during the neonatal period. Dietary control of blood Phe <900 mmol/L was maintained in 23 of these children beyond 10 years of age; in 72 others, the blood Phe level was persistently >900 mmol/L at varying ages. Test scores were negatively correlated with age at initiation of diet and with blood Phe levels from ages 4 to 10 years, and were positively correlated with parent intelligence quotient (IQ) scores and age when dietary control was lost.

The findings of that study and others have gradually resulted in a philosophy of a "Diet for Life" at most clinics in the United States. In preparation for the Consensus Development Conference on Phenylketonuria (PKU), the National Institute of Child Health and Human Development (NICHD) authorized funding to conduct a followup study on the enrollees in the study, who are now 27 to 32 years old, and to compare the findings with the data collected on the subjects during childhood. The followup effort is still under way, and this abstract presents an initial summary of the results to date.

Sample

After a 15-year interval between the 2 studies, 59 of the 129 enrollees who were still active at the end of the original study were located and evaluated. There were no significant differences between those who were and those who were not evaluated as adults on diagnostic, treatment, demographic, or childhood psychometric variables. Seven of the 59 never discontinued diet, whereas 30 discontinued before 6.5 years of age, 12 between 6.5 years and 12 years of age, and 10 between 12 and 20 years of age. Among discontinuers, nine had 3 or more additional years of treatment.

Results

Medical findings as reported by questionnaire and current medical evaluation are summarized in Table 1. Eczema was reported in 26 percent, recurrent headache in 28 percent, neurological signs in 26 percent, hyperactivity in 15 percent, and lethargy in 20 percent of the subjects off diet, and in none of those who remained on a Phe-restricted diet. Furthermore, these symptoms were more common in those who discontinued dietary treatment before 6.5 years of age. In those off diet, depression was reported in 24 percent, phobias in 24 percent, and unspecified mental disorders in 15 percent. In comparison, the on-diet group had only one reported episode of transient depression, and that was related to a medical product change. Intellectual development and academic achievement were measured by the Wechsler Adult Intelligence Scale-Revised (WAIS-R) and the WRAT-3, respectively. The mean standard scores have remained fairly stable since age 12, as shown in Figures 1 and 2. One interesting phenomenon is that arithmetic scores on the WRAT-3 are much improved in adulthood when compared with scores at age 12. Because extensive neuropsychological testing on a subset of 20 subjects is still in process, however, our followup study is incomplete at this time.

Table 1. Medical findings in 52 PKUCS adult subjects

Findings <6.5 yr 6.5-12.5 yr >12.5 yr Never Total Sample
n % n % n % n % n %
Convulsions 1 4 0 0 0 0 0 0 1 2
Eczema 10 8.33% 1 9 1 8 0 0 12 23
Hyperactivity 4 17 2 18 1 8 0 0 7 13
Hypoactivity/lethargy 8 35 0 0 1 8 0 0 9 18
Autistic behavior 0 0 0 0 0 0 0 0 0 0
Phobias 7 30 1 9 3 25 1 17 12 23
Depression 8 35 1 9 2 17 1 17 12 23
Headaches 7 30 2 18 4 33 0 0 13 25
Mental disorders 5 22 1 9 1 8 0 0 7 13
Surgery 15 62 3 27 5 42 1 17 24 46
Heart disease 1 4 0 0 0 0 0 0 1 2
Hypertension 1 4 2 18 0 0 2 33 5 10
Cancer 0 0 0 0 0 0 0 0 0 0
Asthma 2 8 2 18 0 0 0 0 4 8
Obesity (BMI >=30) 4 16 3 27 0 0 2 9 9 16
Neurological Signs 4 22 4 40 2 18 0 0 10 22

Figure 1. Wechsler IQ test scores, PKUCS adult followup study**

**Not corrected for mutation severity, parental IQ, brain Phe level, or age of diagnosis.

graph of verbal, performance, full scale in 8, 10, 12 years, adult; iqs are high

Figure 2. Wide Range Achievement test scores, PKUCS adult followup study

graph of reading, spelling, aritmetic in 8, 10, 12 years, adult; scores are high except in arithmetic

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy (MRI/MRS) Findings

Fifteen subjects have completed this part of the study. Brain Phe levels were measured with simultaneous blood samples. (See Table 2.) Blood Phe did not predict brain Phe levels, although three of the six persons with low brain Phe levels exhibited blood Phe levels of 900, 255, and 151  mmol/L. The other three persons with low brain Phe levels, exhibited blood Phe levels of 1,965, 1,591, and 1,560 mmol/L. Mean IQ in persons with the six lowest brain Phe levels was 109, and in those with the nine highest brain Phe levels it was 104. The sample size, however, is too small for meaningful statistical comparison.

MRI codes ranged from 0 to 5, where 0 indicates complete normality and 5 indicates severe abnormality. One subject was rated as 0, six as 1, five as 2, and two as 3. There were no subjects in categories 4 and 5. By grouping ratings 0 and 1, the mean IQ of seven subjects was 112; by combining 2 and 3, the mean IQ in seven subjects was 102. Again, the sample is too small for meaningful comparisons. Five subjects remain to be studied, and these studies will be completed by September 2000.

Table 2. MRI/MRS findings to date

* At end of PKU study in 1984.+ Plan to repeat MRI/MRS. Subject data were accidentally erased.

C Continuer of Phe-restricted diet. Mean IQ = 112.0.

D Discontinuer of Phe-restricted diet. Mean IQ = 103.

Subject ID Diet Status* Age Diet Discontinued WAIS-R IQ MRI Code MRS Brain
Phe mm/L
Blood Phe mmol/L
L36 14 102 2 0.55 1500
L30 C - 103 1 0.34 1111
I17 C 12 124 1 0.19 1965
L22 C - 113 2 0.22 900
L18 C - 123 3 0.41 1371
Q04 C - 108 1 0.18 0255
A08 C - 112 1 0.16 0151
L01 D 6 116 2 0.92 1440
L07 D 6 126 1 0.35 1185
L27 D 5 75 3 0.45 1620
L13 D 6 105 Not done Agoraphobic 1500
L32 D 6 101 2 0.35 1080
S07 D 7 102 1 0.31 1137
L10 D 8 114 0 0.16 1591
S01 D 6 83 2 0.22 1560

Adult Test Scores for Subjects Grouped by Age at Which Diet Was Discontinued

Continuers on diet had a higher mean full-scale IQ score of 108, which represents a significant increase over their 12-year mean WISC-R IQ ( p=0.03) score. (See Table 3.) Subjects who discontinued dietary treatment before 6.5 years of age had a mean IQ of 90, whereas those who discontinued dietary treatment between 6.5 and 12.5 years of age scored a mean IQ of 95. Those who stayed on diet longer than 12 years scored a mean IQ of 99. None of the mean scores of those off diet differed from their mean scores at age 12. WRAT-3 achievement test scores appear to be higher in those who remained on diet, although the sample size was too small for statistical testing.

*Change from 12-year WISC-R or WRAT score.
p-values are for illustration only, due to small sample sizes.

Age Diet Discontinued WAIS-R WRAT 3
n Verbal Performance Full n Reading Spelling Arithmetic
Before 6.5 years Parent IQ 23 104 +-10
Before 6.5 years Adult score 24 88 +-11 94 +-16 89 +-12 90 +-13 20 94 +-12 92 +-14
Before 6.5 years Change* 20 -1 +2 +9 0 16 0 +3
Before 6.5 years p 0.58 0.49 0.001 0.98 0.83 0.29
6.5-12.5 years Parent IQ 12 110 +-8
6.5-12.5 years Adult score 13 93 +-15 97 +-22 91 +-6 95 +-18 12 98 +-18 94 +-17
6.5-12.5 years Change* 5 0 -2 +10 -1 8 +1 +2
6.5-12.5 years p 1.00 0.70 0.03 0.73 0.62 8.33%
12.5-20 years Parent IQ 8 102 +-15
12.5-20 years Adult score 8 97 +-16 102 +-20 89 +-31 99 +-19 4 91 +-32 91 +-31
12.5-20 years Change* 8 +5 +3 +9 +4 3 -3 -9
12.5-20 years p 0.18 8.33% 0.08 0.35 0.38 0.28
Never Off Diet Parent IQ 7 111 +-7
Never Off Diet Adult score 7 110 +-9 105 +-12 98 +-5 108 +-8 5 109 +-5 110 +-6
Never Off Diet Change* 6 +12 +6 +16 +10 3 +2 +8
Never Off Diet P 0.01 0.29 0.01 0.03 0.51 0.06

Adult Test Scores for Subjects Grouped by Current Phe Levels

The importance of blood Phe is shown by the progressive decline in adult mean IQ scores with increasing blood Phe.(See Table 4.)In 21 adults with blood levels <1,200 m mol/L (range 230 to 1,156), the mean IQ was 103.In 29 adults with blood levels >1,200 m mol/L, the mean IQ was 89. The difference of 14 points in IQ between the two groups is remarkable when one takes into account that the parental mean IQ of the two groups differed by only 2 points.

Table 4. Adult test scores for PKUCS subjects grouped by usual adult Phe level (values tabulated are mean + s.d.)

*Change from 12-year WISC-R or WRAT score.† p-values are for illustration only, due to small sample sizes.

Usual Phe Level WAIS-R WRAT 3
n Verbal Performance Full n Reading Spelling Arithmetic
<15.9 mg/dL Parent IQ 9 108 +-5
<15.9 mg/dL Adult score 9 109 +-10 113 +-14 115 +-6 7 +1 +5 +16
<15.9 mg/dL Change* 9 +6 +7 +8 0 16 0 +3
<15.9 mg/dL p 0.20 0.10 0.08 0.98 0.71 0.25 0.002
16.0-19.9 mg/dL Parent IQ 12 102 +-8 8
16.0-19.9 mg/dL Adult score 13 95 +-12 101 +-13 97 +-13 7 101 +-8 16.66% +-6 95 +-7
16.0-19.9 mg/dL Change* 11 +3 +3 +2 +3 +3 +12
16.0-19.9 mg/dL p 0.28 0.40 0.37 0.21 0.47 0.008
20.0-23.9 mg/dL Parent IQ 11 108 +-9
20.0-23.9 mg/dL Adult score 12 93 +-16 92 +-18 92 +-15 9 95 +-12 96 +-14 89 +-8
20.0-23.9 mg/dL Change* 8 +5 +5 +5 6 -2 +4 +10
20.0-23.9 mg/dL p 0.10 0.49 0.18 0.67 0.47 0.01
20.0-23.9 mg/dL Parent IQ 8 16.66% +-13
20.0-23.9 mg/dL Adult score 8 85 +-15 89 +-13 85 +-14 6 82 +-27 79 +-26 78 +-25
20.0-23.9 mg/dL Change* 6 -4 +6 -3 4 -2 -1 +8
20.0-23.9 mg/dL P 0.32 0.29 0.39 0.63 0.82 0.14
24.0-27.9 mg/dL Parent IQ 8 16.66% +-13
24.0-27.9 mg/dL Adult score 8 85 +-15 89 +-13 85 +14 6 82 +-27 79 +-26 78 +-25
24.0-27.9 mg/dL Change* 6 -1 -4 -3 4 -2 -1 +8
24.0-27.9 mg/dL P 0.76 0.32 0.39 0.63 0.82 0.14
=>28.0 mg/dL Parent IQ 9 106 +-12
=>28.0 mg/dL Adult score 9 88 +-12 95 +-20 90 +-16 9 94 +-18 92 +-17 16.66% +-16
=>28.0 mg/dL Change* 6 -2 0 -2 7 -1 -2 +3
=>28.0 mg/dL P 0.37 0.90 0.31 0.85 0.57 0.39

Educational and Occupational Status

In the group of adults with PKU, 32 percent were college graduates, 21 percent had professional- level occupations, and 20 percent were in the highest two Hollingshead socioeconomic classes. Although the percentages are higher with increased years of dietary treatment and lower Phe levels, even among those who discontinued diet before age 12.5 years, 21 percent were college graduates and 14 percent reported professional occupations. The present study also collected educational and occupational data on siblings. In comparisons between 24 pairs of adults with PKU and their adult non-PKU siblings, the percentages who were college graduates were identical (37.5 percent), as were the percentages in professional occupations (25 percent).

Mutation Studies of the Phenylalanine Hydroxylase Enzyme

Mutation studies were performed by a group in Glostrup, Denmark, headed by Flemming Güttler.A discussion of these is beyond the scope of this report, but it may suffice to say that only four subjects exhibited one mild mutation on chromosome number 12. Thus, the diagnosis of classical PKU was confirmed by the mutation studies.

Conclusion

In summary, the data collected so far favor diet continuation through adulthood. Both the higher frequency of reported medical and mental disorders and the lower cognitive test scores among discontinuers support this practice. In addition, the newer medical food products now available and the possibility, based on knowledge gained from MRI/MRS studies, of therapy with large neutral amino acids as an adjunct to dietary restriction of Phe, provide encouragement that care of individuals with PKU will be better in the future.

References

  • Holtzman NA, Kronmal RA, Van Doornick W, Azen C, Koch R 1916.66%. Effect of age at loss of dietary control on intellectual performance and behavior in children with phenylketonuria. N Engl J Med 314:593-596.
  • Azen C, Koch R, Friedman EG, et al. 1991. Intellectual development in 12 year-old children treated for phenylketonuria. Am J Dis Child 145:35-39.

Back to Abstracts

first | previous | next | last

Last Updated Date: 08/28/2006
Last Reviewed Date: 08/28/2006
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology